This index is particularly useful for healthcare professionals, researchers, and individuals seeking detailed information about specific branded pharmaceutical product.
Monographs serve as essential reference for clinical particulars such as drug composition and administration guidelines, indications, contraindications and adverse reactions.
| Document | Type | Information Source | |
|---|---|---|---|
| JADELLE Implant | MPI, EU: SmPC | Medicines and Medical Devices Safety Authority (NZ) | |
| JADENU Film-coated tablet / Granules | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| JAKAVI Oral solution | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JAKAVI Tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JALRA Tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JALRAMET Film-coated tablet | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| JALYN Capsule | MPI, US: SPL/PLR | FDA, National Drug Code (US) | |
| JANUMET Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JANUVIA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JAPROLOX Patch | MPI, EU: SmPC | ||
| JARDIANCE Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JAVLOR Concentrate for solution for infusion | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JAYDESS Intrauterine delivery system | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| JAYEMPI Oral suspension | MPI, EU: SmPC | European Medicines Agency (EU) | |
| JAYPIRCA Film-coated tablet | MPI, EU: SmPC | European Medicines Agency (EU) |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.